Co-Mutation Features In Treatment-Naive Egfr-Mutant Lung Adenocarcinoma.

Jun Zhao,Zaiwen Fan,Donghong Chen,Minglei Zhuo,Zhen Liang,Lin Li, Yun Gao,Xiaorong Wang,Zhuo Yu,Cunliang Cai,Dapeng Dong,Jingquan Zhao,Wenguang Gu,Min Zhang,Rongrong Chen,Xuefeng Xia

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 0|浏览15

暂无评分

摘要

e21616Background: In Chinese patients with lung adenocarcinoma, the positive rate of EGFR mutation was 40% - 50%, EGFR-TKIs therapy for lung cancer was also aimed at this part of patients. However,...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要